教室紹介、スタッフ紹介、研究、業績等、順天堂大学大学院 分子病理病態学に関する様々な情報をご案内します。


業績


 

論文、学会活動など

 
  1. Matsumoto, F., Fujii, H., Abe, M., Kajino, K., Kobayashi, T., Matsumoto, T., Ikeda, K. and Hino O.: A novel tumor marker, Niban, is expressed in subsets of thyroid tumors and Hashimoto’s thyroiditis. Human Pathology, in press
  2. Shiomi K, Miyamoto H, Segawa T, Hagiwara Y, Ota A, Maeda M, Takahashi K, Masuda K, Sakao Y and Hino O.: A novel ELISA system for detection of a“N-ERC/Mesothelin” in the sera of mesothelioma patients. Cancer Sci, in press
  3. Togashi Y, Kobayashi T, Momose S, Ueda M, Okimoto K, and Hino O. Transgenic rescue from embryonic lethality and renal carcinogenesis in the Nihon rat model by introduction of a wild-type Bhd gene. Oncogene 25: 2885-2889, 2006
  4. Hino O., Kobayashi T. and Okimoto K.: Genetic and environmental factors in hereditary predisposition to tumors: a conceptual overview. Cancer: Cell Structures, Carcinogens and Genomic Instability. Edited by Leon P. Bignold. Birkhauser Verlag. 269-292, 2006
  5. Yasen M., Kajino K., Kano S., Tobita H., Yamamoto J., Uchiumi T., Kon S., Maeda M., Obulhasim G., Arii S. and Hino O.: The up-regulation of Y box binding proteins (dbpA and YB-1) as prognostic markers of hepatocellular carcinoma. Clinical Cancer Research 11: 7354-7361, 2005
  6. Ma L., Teruya-Feldstein J., Behrendt N., Chen Z., Noda T., Hino O., Cordon-Cardo C. and Pandolfi P.P.: Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor. Genes & Development, 19: 1779-1986, 2005
  7. Ishii T., Yasuda K., Akatsuka A., Hino O., Hartman P.S. and Ishii N.: A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis. Cancer Research, 65: 203-209, 2005
  8. Okimoto K., Kouchi M., Matsumoto I., Sakurai J., Kobayashi T. and Hino O.: Natural history of the Nihon rat model of BHD. Current Molecular Medicine, 4: 887-893, 2004
  9. Hino O.: Multistep renal carcinogenesis in the Eker (Tsc 2 gene mutant) rat model. Current Molecular Medicine, 4: 807-811, 2004 
  10. Adachi H., Majima S., Kon S., Kobayashi T., Kajino K., Mitani H., Shiina H., Igawa M. and Hino O.: The Niban gene is commonly expressed in renal tumors: A new candidate marker for renal carcinogenesis. Oncogene, 23:3495-3500, 2004
  11. Okimoto K., Sakurai J., Kobayashi T., Mitani H., Hirayama Y., Nickerson M. L., Warren M. B., Zbar B., Schmidt L. S. and Hino O.: A germline insertion in the Birt-Hogg-Dube' (BHD) gene gives rise to the Nihon Rat model of inherited renal cancer. Proc Natl Acad Sci USA 101:2023-2027, 2004
  12. Hino O.: Hereditary renal carcinogenesis fitting Knudson's two-hit model: genotype, environment, and phenotype. Genes Chromosomes Cancer 38: 357-367, 2003
  13. Momose S., Kobayashi T., Mitani H., Hirabayashi M., Ito K., Ueda M., Nabeshima Y. and Hino O.: Identification of the coding sequences responsible for Tsc2-mediated tumor suppression using a transgenic rat system. Hum Mol Genet 11: 2997-3006, 2002
  14. Gao X., Zhang Y., Arrazola P., Hino O., Kobayashi T., Yeung R. S., Ru B. and Pan D.: Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat Cell Biol 4: 699-704, 2002
  15. Kobayashi T., Minowa O., Sugitani Y., Takai S., Mitani H., Kobayashi E., Noda T. and Hino O.: A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice. Proc Natl Acad Sci U S A 98: 8762-8767, 2001
  16. Aoki H., Hayashi J., Moriyama M., Arakawa Y. and Hino O.: Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1. J Virol 74: 1736-1741, 2000
  17. Hayashi J., Aoki H., Kajino K., Moriyama M., Arakawa Y. and Hino O.: Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor alpha. Hepatology 32: 958-961, 2000
  18. Kobayashi T., Mitani H., Takahashi R., Hirabayashi M., Ueda M., Tamura H. and Hino O.: Transgenic rescue from embryonic lethality and renal carcinogenesis in the Eker rat model by introduction of a wild-type Tsc2 gene. Proc Natl Acad Sci U S A 94: 3990-3993, 1997
  19. Aoki H., Kajino K., Arakawa Y. and Hino O.: Molecular cloning of a rat chromosome putative recombinogenic sequence homologous to the hepatitis B virus encapsidation signal. Proc Natl Acad Sci U S A 93: 7300-7304, 1996
  20. Kobayashi T., Hirayama Y., Kobayashi E., Kubo Y. and Hino O.: A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat Genet 9: 70-74, 1995
  21. Hino O., Klein-Szanto A. J., Freed J. J., Testa J. R., Brown D. Q., Vilensky M., Yeung R. S., Tartof K. D. and Knudson A. G.: Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer. Proc Natl Acad Sci U S A 90: 327-331, 1993
  22. Hino O., Testa J. R., Buetow K. H., Taguchi T., Zhou J. Y., Bremer M., Bruzel A., Yeung R., Levan G., Levan K. K. and et al.: Universal mapping probes and the origin of human chromosome 3. Proc Natl Acad Sci U S A 90: 730-734, 1993
  23. Hino O., Tabata S. and Hotta Y.: Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA. Proc Natl Acad Sci U S A 88: 9248-9252, 1991
  24. Hino O., Shows T. B. and Rogler C. E.: Hepatitis B virus integration site in hepatocellular carcinoma at chromosome 17;18 translocation. Proc Natl Acad Sci U S A 83: 8338-8342, 1986
 


Copyright © 2005 JUNTENDO All Rights Reserved.